Dataset Information

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.

ABSTRACT: Common variants at only two loci, FTO and MC4R, have been reproducibly associated with body mass index (BMI) in humans. To identify additional loci, we conducted meta-analysis of 15 genome-wide association studies for BMI (n > 32,000) and followed up top signals in 14 additional cohorts (n > 59,000). We strongly confirm FTO and MC4R and identify six additional loci (P < 5 x 10(-8)): TMEM18, KCTD15, GNPDA2, SH2B1, MTCH2 and NEGR1 (where a 45-kb deletion polymorphism is a candidate causal variant). Several of the likely causal genes are highly expressed or known to act in the central nervous system (CNS), emphasizing, as in rare monogenic forms of obesity, the role of the CNS in predisposition to obesity.

SUBMITTER: Willer CJ

PROVIDER: S-EPMC2695662 | biostudies-literature | 2009 Jan

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.

Willer Cristen J CJ Speliotes Elizabeth K EK Loos Ruth J F RJ Li Shengxu S Lindgren Cecilia M CM Heid Iris M IM Berndt Sonja I SI Elliott Amanda L AL Jackson Anne U AU Lamina Claudia C Lettre Guillaume G Lim Noha N Lyon Helen N HN McCarroll Steven A SA Papadakis Konstantinos K Qi Lu L Randall Joshua C JC Roccasecca Rosa Maria RM Sanna Serena S Scheet Paul P Weedon Michael N MN Wheeler Eleanor E Zhao Jing Hua JH Jacobs Leonie C LC Prokopenko Inga I Soranzo Nicole N Tanaka Toshiko T Timpson Nicholas J NJ Almgren Peter P Bennett Amanda A Bergman Richard N RN Bingham Sheila A SA Bonnycastle Lori L LL Brown Morris M Burtt Noël P NP Chines Peter P Coin Lachlan L Collins Francis S FS Connell John M JM Cooper Cyrus C Smith George Davey GD Dennison Elaine M EM Deodhar Parimal P Elliott Paul P Erdos Michael R MR Estrada Karol K Evans David M DM Gianniny Lauren L Gieger Christian C Gillson Christopher J CJ Guiducci Candace C Hackett Rachel R Hadley David D Hall Alistair S AS Havulinna Aki S AS Hebebrand Johannes J Hofman Albert A Isomaa Bo B Jacobs Kevin B KB Johnson Toby T Jousilahti Pekka P Jovanovic Zorica Z Khaw Kay-Tee KT Kraft Peter P Kuokkanen Mikko M Kuusisto Johanna J Laitinen Jaana J Lakatta Edward G EG Luan Jian'an J Luben Robert N RN Mangino Massimo M McArdle Wendy L WL Meitinger Thomas T Mulas Antonella A Munroe Patricia B PB Narisu Narisu N Ness Andrew R AR Northstone Kate K O'Rahilly Stephen S Purmann Carolin C Rees Matthew G MG Ridderstråle Martin M Ring Susan M SM Rivadeneira Fernando F Ruokonen Aimo A Sandhu Manjinder S MS Saramies Jouko J Scott Laura J LJ Scuteri Angelo A Silander Kaisa K Sims Matthew A MA Song Kijoung K Stephens Jonathan J Stevens Suzanne S Stringham Heather M HM Tung Y C Loraine YC Valle Timo T TT Van Duijn Cornelia M CM Vimaleswaran Karani S KS Vollenweider Peter P Waeber Gerard G Wallace Chris C Watanabe Richard M RM Waterworth Dawn M DM Watkins Nicholas N Witteman Jacqueline C M JC Zeggini Eleftheria E Zhai Guangju G Zillikens M Carola MC Altshuler David D Caulfield Mark J MJ Chanock Stephen J SJ Farooqi I Sadaf IS Ferrucci Luigi L Guralnik Jack M JM Hattersley Andrew T AT Hu Frank B FB Jarvelin Marjo-Riitta MR Laakso Markku M Mooser Vincent V Ong Ken K KK Ouwehand Willem H WH Salomaa Veikko V Samani Nilesh J NJ Spector Timothy D TD Tuomi Tiinamaija T Tuomilehto Jaakko J Uda Manuela M Uitterlinden André G AG Wareham Nicholas J NJ Deloukas Panagiotis P Frayling Timothy M TM Groop Leif C LC Hayes Richard B RB Hunter David J DJ Mohlke Karen L KL Peltonen Leena L Schlessinger David D Strachan David P DP Wichmann H-Erich HE McCarthy Mark I MI Boehnke Michael M Barroso Inês I Abecasis Gonçalo R GR Hirschhorn Joel N JN

Nature genetics 20081214 1

Common variants at only two loci, FTO and MC4R, have been reproducibly associated with body mass index (BMI) in humans. To identify additional loci, we conducted meta-analysis of 15 genome-wide association studies for BMI (n > 32,000) and followed up top signals in 14 additional cohorts (n > 59,000). We strongly confirm FTO and MC4R and identify six additional loci (P < 5 x 10(-8)): TMEM18, KCTD15, GNPDA2, SH2B1, MTCH2 and NEGR1 (where a 45-kb deletion polymorphism is a candidate causal variant) ...[more]

PMID: 19079261

Similar Datasets

Project description:Depression and obesity are complex global health problems. Recent studies suggest that a genetic predisposition to obesity might be accentuated in people with depression, but these analyses are prone to bias. Here, we tested the hypothesis that depression accentuates genetic susceptibility to obesity and applied negative control experiments to test whether any observed interactions were real or driven by confounding and statistical biases. We used data from up to 378 000 Europeans in UK Biobank, a 73 variant body mass index (BMI) genetic risk score, two depression measures [depression symptoms (DS), major depression (MD)] and an antidepressant usage variable available. We tested whether (i) depression and (ii) antidepressant treatment accentuated genetic susceptibility to obesity. Finally, we performed negative control experiments by sampling individuals at random so that they had BMI distributions identical to depression cases and controls. Depression was associated with an accentuation of an individual's genetic risk of obesity with evidence of interactions for both DS and MD (Pinteraction = 7 × 10-4 and 7 × 10-5 respectively). Antidepressant usage within DS cases accentuated genetic obesity risk (Pinteraction = 9 × 10-4), but not for MD (Pinteraction = 0.13). Negative control experiments suggested that the observed interactions for MD (empirical-P = 0.067) may be driven by statistical biases or confounding factors but were not possible with the larger DS groups. Antidepressant usage interaction also appears to be driven by statistical artefacts (empirical-P = 0.510 using MD and 0.162 using DS). We have highlighted the importance of running negative experiments to confirm putative interactions in gene-environment studies. We provide some tentative evidence that depression accentuates an individual's genetic susceptibility to higher BMI but demonstrated that the BMI distributions within cases and controls might drive these interactions.

Project description:OBJECTIVE:Overweight and obese women may avoid contraceptive methods they believe are associated with weight gain. The objective of this study was to examine the role of weight and weight perception on contraceptive use. STUDY DESIGN:Using cross-sectional data from the MyNewOptions study, we analyzed contraceptive use among 987 privately insured, sexually active women aged 18-40 years. Contraception was categorized into three groups: (1) long-acting reversible contraceptives (LARCs), (2) non-LARC prescription methods and (3) nonprescription methods/no method. Multinomial logistic regression was used to model the effect of body mass index category and weight perception on contraceptive use while controlling for pregnancy intentions, sexual behavior and sociodemographic characteristics. RESULTS:Eighty-three (8.4%) women were using LARCs, 490 (49.6%) women were using non-LARC prescription methods and 414 (42.0%) were using nonprescription methods or no method. In the adjusted multinomial model, overweight [adjusted odds ratio (aOR) 3.84, 95% confidence interval (CI) 1.85-7.98) and obese women (aOR 2.82, 95% CI 1.18-6.72) were significantly more likely to use LARCs compared to normal-weight women. There were greater adjusted odds of overweight and obese women using nonprescription methods/no method compared with non-LARC prescription methods, but this finding did not reach statistical significance. Weight perception was not associated with contraceptive use. CONCLUSION:In this study sample, overweight and obese women were more likely to use LARCs than normal-weight women. It will be important to further understand how weight influences women and providers' views on contraception in order to better assist women with individualized, patient-centered contraceptive decision making. IMPLICATIONS:Overweight and obese women may be reluctant to use contraceptive methods they believe are associated with weight gain (i.e., pills, shot), but how that affects contraceptive use is unclear. Compared with normal-weight women, overweight and obese women in this study were more likely to use LARCs than non-LARC prescription methods.

Project description:BackgroundChildren with familial dysautonomia (FD) are smaller and grow more slowly than the general population. It is unknown whether this abnormal growth is due to comorbidities that patients with FD live with, or if it is a direct effect of the disease-causing homozygous ELP-1 mutations. Here, we created growth curves for weight, height, and body mass index (BMI) in male and female children with FD to monitor the nutritional status of patients with FD.MethodsWe used the New York University (NYU) FD Registry which includes data from 680 individuals with FD who were followed longitudinally since birth. We generated sex-specific FD growth charts for three age ranges (birth to 36 months, 2 to 20 years, and 2 to 40 years) and compared them to the general population. We generated Kaplan-Meier curves to test the hypothesis that FD patients with low BMI had shorter survival than the rest of the cohort.ResultsGrowth charts generated from 591 individuals with FD show that these patients grow more slowly, reach less height, and gain less weight than the general population. The impact of FD on height was more pronounced in girls than in boys. However, both groups showed markedly low weights, which resulted in low BMI. Low weight, but not height, is already evident at birth. In a subpopulation of FD patients, we found that treatment with growth hormone or spinal fusion surgery helped patients achieve the expected growth characteristic of FD patients, but these treatments did not lead FD patients to achieve the growth pattern of the general population. Contrary to our hypothesis, low BMI had no impact on patient survival.ConclusionsPediatric patients with FD have lower height, weight, and BMI compared to the general pediatric population, but this does not appear to affect survival. Growth curves specific to the FD population are an important tool to monitor growth and nutritional status in pediatric patients with FD when the general population growth curves are of limited use.

Dataset Information

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.

Publications

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets